Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment

Abstract Background It is well known that the incidence of developing hepatocelluler carcinoma (HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC incidence in various liver diseases has not yet been estimated. We surveyed this comparison. Methods The PubMed dat...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1998
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576216410882048
author Kazuo Tarao
Akito Nozaki
Takaaki Ikeda
Akira Sato
Hirokazu Komatsu
Tatsuji Komatsu
Masataka Taguri
Katsuaki Tanaka
author_facet Kazuo Tarao
Akito Nozaki
Takaaki Ikeda
Akira Sato
Hirokazu Komatsu
Tatsuji Komatsu
Masataka Taguri
Katsuaki Tanaka
author_sort Kazuo Tarao
collection DOAJ
description Abstract Background It is well known that the incidence of developing hepatocelluler carcinoma (HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC incidence in various liver diseases has not yet been estimated. We surveyed this comparison. Methods The PubMed database was examined (1989‐2017) for studies published in English language regarding the prospective follow‐up results for the development of HCC in various liver diseases. A meta‐analysis was performed for each liver disease. Results The annual incidence (%) of HCC in the non‐cirrhotic stage and cirrhotic stage, and the ratio of HCC incidence in the cirrhotic stage/non‐cirrhotic stage were as follows. (a) hepatitis B virus liver disease: 0.37%→3.23% (8.73‐fold), (b) hepatitis C virus liver diseases: 0.68%→4.81% (7.07‐fold), (c) primary biliary cholangitis (0.26%→1.79%, 6.88‐fold), (d) autoimmune hepatitis (0.19%→0.53%, 2.79‐fold), and (e) NASH (0.03%→1.35%, 45.00‐fold). Regarding primary hemochromatosis and alcoholic liver diseases, only follow‐up studies in the cirrhotic stage were presented, 1.20% and 2.06%, respectively. Conclusions When the liver diseases advance to cirrhosis, the incidence of HCC is markedly increased. The development of HCC must be closely monitored by ultrasonography, magnetic resonance imaging, and computed tomography, irrespective of the different kinds of liver diseases.
format Article
id doaj-art-917e83215cb3434baf77b3b8c3145ee1
institution Kabale University
issn 2045-7634
language English
publishDate 2019-03-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-917e83215cb3434baf77b3b8c3145ee12025-01-31T08:47:42ZengWileyCancer Medicine2045-76342019-03-01831054106510.1002/cam4.1998Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessmentKazuo Tarao0Akito Nozaki1Takaaki Ikeda2Akira Sato3Hirokazu Komatsu4Tatsuji Komatsu5Masataka Taguri6Katsuaki Tanaka7Tarao’s Gastroenterological Clinic Yokohama JapanGastroenterological Center, Medical Center Yokohama City University Yokohama JapanGastroenterology Department Yokosuka General Hospital Uwamachi Yokosuka JapanDivision of Gastroenterology, Department of Internal Medicine St. Marianna University, Yokohama City Seibu Hospital Yokohama JapanDepartment of Gastroenterology Yokohama Municipal Citizen’s Hospital Yokohama JapanDepartment Clinical Research National Hospital Organization, Yokohama Medical Center Yokohama JapanDepartment of Data Science Yokohama City University Yokohama JapanHatano Red Cross Hospital Kanagawa JapanAbstract Background It is well known that the incidence of developing hepatocelluler carcinoma (HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC incidence in various liver diseases has not yet been estimated. We surveyed this comparison. Methods The PubMed database was examined (1989‐2017) for studies published in English language regarding the prospective follow‐up results for the development of HCC in various liver diseases. A meta‐analysis was performed for each liver disease. Results The annual incidence (%) of HCC in the non‐cirrhotic stage and cirrhotic stage, and the ratio of HCC incidence in the cirrhotic stage/non‐cirrhotic stage were as follows. (a) hepatitis B virus liver disease: 0.37%→3.23% (8.73‐fold), (b) hepatitis C virus liver diseases: 0.68%→4.81% (7.07‐fold), (c) primary biliary cholangitis (0.26%→1.79%, 6.88‐fold), (d) autoimmune hepatitis (0.19%→0.53%, 2.79‐fold), and (e) NASH (0.03%→1.35%, 45.00‐fold). Regarding primary hemochromatosis and alcoholic liver diseases, only follow‐up studies in the cirrhotic stage were presented, 1.20% and 2.06%, respectively. Conclusions When the liver diseases advance to cirrhosis, the incidence of HCC is markedly increased. The development of HCC must be closely monitored by ultrasonography, magnetic resonance imaging, and computed tomography, irrespective of the different kinds of liver diseases.https://doi.org/10.1002/cam4.1998hepatocellular carcinomaliver cirrhosisliver diseasesmeta‐analysisrisk of HCC
spellingShingle Kazuo Tarao
Akito Nozaki
Takaaki Ikeda
Akira Sato
Hirokazu Komatsu
Tatsuji Komatsu
Masataka Taguri
Katsuaki Tanaka
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
Cancer Medicine
hepatocellular carcinoma
liver cirrhosis
liver diseases
meta‐analysis
risk of HCC
title Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
title_full Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
title_fullStr Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
title_full_unstemmed Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
title_short Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
title_sort real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases meta analytic assessment
topic hepatocellular carcinoma
liver cirrhosis
liver diseases
meta‐analysis
risk of HCC
url https://doi.org/10.1002/cam4.1998
work_keys_str_mv AT kazuotarao realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT akitonozaki realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT takaakiikeda realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT akirasato realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT hirokazukomatsu realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT tatsujikomatsu realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT masatakataguri realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment
AT katsuakitanaka realimpactoflivercirrhosisonthedevelopmentofhepatocellularcarcinomainvariousliverdiseasesmetaanalyticassessment